Explore our ACCC 2020 Impact Report, the Oncology Issues, Vol.36, N.3, and our video podcast, CANCER BUZZ TV.

Industry News Archive

The Leading Expert Views on the Role of MRD in Patient Care

The body of evidence supporting measurable residual disease (MRD) assessment in routine patient care is growing. Leading experts share their views on MRD, the evolving role of MRD testing in lymphoid cancers, and insights on incorporating clonoSEQ (Adaptive Biotechnologies) into clinical practice decisions to assess MRD.

Read article.

Posted on 5/14/2021


1801 Research Boulevard Suite 400
Rockville, MD 20850
Tel: 301.984.9496 | Fax: 301.770.1949
txsco.com
Email Us